does glp 1 build up in the body Understanding GLP-1 Stopping GLP-1s: Weight Regain and

Front Endocrinol 13(July):114 Htike ZZ, Zaccardi F, Papamargaritis D, Webb DR, Khunti K, Davies MJ (2017) Efficacy and safety of glucagon-like peptide-1 receptor agonists in type 2 diabetes: A systematic review and mixed-treatment comparison analysis

The exact response depends on the medication, dose, health history, diet, activity, and individual tolerance

Numbness Temporary numbness or tingling in the treated area may occur but typically resolves within a few days

It has attracted significant attention in laboratory research due to its interaction with angiogenic pathways, nitric oxide signaling, and cytoprotective mechanisms